Phase II Trial for the Treatment of Advanced Classical Kaposi's Sarcoma With the HIV Protease Inhibitor Indinavir in Combination With Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2018
At a glance
- Drugs Bleomycin (Primary) ; Indinavir (Primary) ; Vinblastine (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 29 Aug 2016 Status changed from active, no longer recruiting to completed.
- 03 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 01 Sep 2015 Planned End Date changed from 1 Sep 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov record.